New shot cuts bad cholesterol in half – phase 3 trial success
NCT ID NCT07295418
First seen Dec 26, 2025 · Last updated May 17, 2026 · Updated 21 times
Summary
This study tested a new medicine called SAL003 in 618 adults with high cholesterol. Participants received either the drug or a placebo every 4 weeks for 12 weeks. The main goal was to see how much it lowered 'bad' LDL cholesterol. The drug is a type of PCSK9 inhibitor, which helps the body remove more cholesterol from the blood. Results showed a significant drop in LDL levels compared to placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERLIPIDEMIAS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking University Third Hospital
Beijing, Beijing Municipality, 100083, China
Conditions
Explore the condition pages connected to this study.